Kristen Ryland
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Lymphoma Diagnosis and Treatment, Hepatitis B Virus Studies
Most-Cited Works
- → Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant(2015)180 cited
- → Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation(2013)102 cited
- → Comparison of miRNA quantitation by Nanostring in serum and plasma samples(2017)93 cited
- → Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis(2015)56 cited
- → Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study(2018)18 cited
- → Hepatic Sarcoidosis: Incidence, Monitoring, and Treatment(2020)10 cited
- → Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL)(2023)1 cited
- → S1318 Liver Transplant Outcomes and Health Care Utilization Resources in African Americans: Are They EquiTable?(2022)
- → Parallel 2: Antivirals, Acute Liver Failure in Liver Transplantation(2014)
- → Letter to the Editor: Reply to “Population Screening for Cirrhosis” by Thiele et al, describing the Florida Healthy Liver Program(2025)